Number of the records: 1
cytarabín
Record number d003561 Date 06.06.2025 Type M Topical term cytarabín Other term English (Pseudonym) Arabinofuranosylcytosine
English (Pseudonym) Arabinosylcytosine
English (Pseudonym) Ara-C
English (Pseudonym) Cytosine Arabinoside
Slovak (Pseudonym) Ara-C
Slovak (Pseudonym) arabinofuranozylcytozín
Slovak (Pseudonym) arabinozylcytozín
Slovak (Pseudonym) Aracytine
Slovak (Pseudonym) aracytidín
Slovak (Pseudonym) cytarabín hydrochlorid
Slovak (Pseudonym) Cytonal
Slovak (Pseudonym) Cytosar
Slovak (Pseudonym) Cytosar-U
Slovak (Pseudonym) cytozín arabinozid
Slovak (Pseudonym) beta-Ara C
See also (Skutočné meno) antimetabolity protinádorové
(Skutočné meno) antivirotiká
(Skutočné meno) imunosupresíva
(Skutočné meno) decitabín
(Later heading) decitabín
UDC D03.383.742.680.245.453D13.570.065.300D13.570.685.245.453 Note A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) 
subject heading
Number of the records: 1